COVID-19 Evidence & Reports
Primary research papers
Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19
Tile subhead - MedRxiv pre-print 21 Sept 2021Read the paper
Tile subhead - Clinical & Experimental Allergy 5th Aug 2021Read the paper
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: an observational cohort
Tile subhead - MedRxiv 03 June 2021Read the paper
Tile subhead - BMJ 10 Mar 2021Read the paper
Tile subhead - Lancet Respiratory Medicine 11 Jan 2021Read the paper
Tile subhead - Infection 25 June 2021Read the paper
Tile subhead - Clinical Infectious Diseases 23 Oct 2020Read the paper
Tile subhead - BMJ 9 Sep 2020Read the paper
Tile subhead - BMJ 27 Aug 2020Read the paper
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19
Tile subhead - BMC Medicine 24 May 2020Read the paper
Tile subhead - BMJ 22 May 2020Read the paper
Tile subhead - Journal of Global Health Jun 2020Read the evidence brief
Tile subhead - BMJ 26 May 2020Read the evidence brief
Current report and dashboard
In March 2020 ISARIC started aggregating data collected from their contributing sites with the aim to produce clinical data reports.
These have been produced using data from the ISARIC COVID-19 clinical data platform.
Thanks to the contributing partners, the submitted data continues to grow allowing for a better understanding of COVID-19.